MFHAS1
Basic information
Region (hg38): 8:8783354-8893630
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (172 variants)
- MFHAS1-related_disorder (11 variants)
- not_provided (10 variants)
- Myoepithelial_tumor (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MFHAS1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000004225.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 13 | 16 | ||||
| missense | 169 | 175 | ||||
| nonsense | 1 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 0 | 169 | 19 | 4 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| MFHAS1 | protein_coding | protein_coding | ENST00000276282 | 3 | 110292 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 4.24e-9 | 0.987 | 125714 | 0 | 34 | 125748 | 0.000135 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | -1.94 | 757 | 621 | 1.22 | 0.0000367 | 6660 |
| Missense in Polyphen | 215 | 225.79 | 0.95221 | 2573 | ||
| Synonymous | -5.73 | 415 | 291 | 1.43 | 0.0000178 | 2293 |
| Loss of Function | 2.36 | 19 | 33.8 | 0.562 | 0.00000202 | 338 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000181 | 0.000181 |
| Ashkenazi Jewish | 0.0000992 | 0.0000992 |
| East Asian | 0.000163 | 0.000163 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000168 | 0.000167 |
| Middle Eastern | 0.000163 | 0.000163 |
| South Asian | 0.000196 | 0.000196 |
| Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Probable GTP-binding protein (PubMed:24286120). Functions in innate immunity and more specifically the inflammatory response as a regulator of the Toll-like receptor TLR2 and TLR4 signaling pathways (PubMed:26599367, PubMed:28471450, PubMed:28609714). Negatively regulates the part of the TLR4 signaling pathway that leads to the activation of the transcription factor AP-1. By retaining the phosphatase complex PP2A into the cytoplasm, prevents the dephosphorylation of the AP- 1 subunit JUN which is required for proper activation of the transcription factor (PubMed:28609714). Both inhibits and activates the TLR2-dependent signaling pathway (PubMed:26599367). Positively regulates the TLR2 signaling pathway to activate specifically the downstream p38 and JNK MAP kinases and promote the polarization of macrophages toward the pro-inflammatory M1 phenotype (PubMed:28471450). It may also play a role in the regulation of inflammation induced by high glucose through the PKB/AKT signaling pathway (PubMed:29168081). Also involved in erythrocyte differentiation through activation of the ERK1/ERK2 signaling pathway (PubMed:23327923). {ECO:0000269|PubMed:23327923, ECO:0000269|PubMed:24286120, ECO:0000269|PubMed:26599367, ECO:0000269|PubMed:28471450, ECO:0000269|PubMed:28609714, ECO:0000269|PubMed:29168081}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving MFHAS1 may be a cause of B-cell lymphoma. Translocation t(8;14)(p23.1;q21) with a cryptic exon named '14q21 element'. The resulting fusion protein named 'chimeric MASL1' is tumorigenic in nude mice. {ECO:0000269|PubMed:14691450}.;
Recessive Scores
- pRec
- 0.116
Intolerance Scores
- loftool
- 0.509
- rvis_EVS
- -1.19
- rvis_percentile_EVS
- 5.89
Haploinsufficiency Scores
- pHI
- 0.105
- hipred
- N
- hipred_score
- 0.394
- ghis
- 0.531
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.410
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mfhas1
- Phenotype
Gene ontology
- Biological process
- inflammatory response;erythrocyte differentiation;negative regulation of toll-like receptor 2 signaling pathway;positive regulation of toll-like receptor 2 signaling pathway;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of protein dephosphorylation;regulation of macrophage activation;innate immune response;positive regulation of JNK cascade;negative regulation of inflammatory response;positive regulation of protein kinase B signaling;positive regulation of ERK1 and ERK2 cascade;negative regulation of protein localization to nucleus;positive regulation of p38MAPK cascade
- Cellular component
- cytoplasm;mitochondrion;lysosome;cytoskeleton
- Molecular function
- protein binding;GTP binding;ubiquitin protein ligase binding;protein phosphatase 2A binding